ID

22475

Description

Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00516542

Link

https://clinicaltrials.gov/show/NCT00516542

Keywords

Versions (1)
  1. 6/5/17 6/5/17 -
Uploaded on

June 5, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT00516542

English

Eligibility Breast Cancer NCT00516542

1 forms  
Criteria
Description

Criteria

diagnosis of breast cancer
Description

ID.1

Data type

boolean

Alias
UMLS CUI [1,1]
C0011900
UMLS CUI [1,2]
C0006142
metastatic disease
Description

ID.2

Data type

boolean

Alias
UMLS CUI [1]
C0027627
hormone receptor status
Description

ID.3

Data type

boolean

Alias
UMLS CUI [1]
C0019929
estrogen receptor- and progesterone receptor-negative
Description

ID.4

Data type

boolean

Alias
UMLS CUI [1,1]
C0279756
UMLS CUI [1,2]
C0279766
androgen receptor-positive
Description

ID.5

Data type

boolean

Alias
UMLS CUI [1]
C2986463
patient characteristics:
Description

ID.6

Data type

boolean

Alias
UMLS CUI [1]
C0815172
ecog performance status 0-3
Description

ID.7

Data type

boolean

Alias
UMLS CUI [1]
C1520224
postmenopausal (> 60 years of age)
Description

ID.8

Data type

boolean

Alias
UMLS CUI [1]
C0232970
leukocyte count > 3,000/ul
Description

ID.9

Data type

boolean

Alias
UMLS CUI [1]
C0023508
absolute neutrophil count > 1,500/ul
Description

ID.10

Data type

boolean

Alias
UMLS CUI [1]
C0200633
platelet count > 100,000/ul
Description

ID.11

Data type

boolean

Alias
UMLS CUI [1]
C0032181
total bilirubin normal
Description

ID.12

Data type

boolean

Alias
UMLS CUI [1]
C0858307
ast and alt < 2.5 times upper limit of normal
Description

ID.13

Data type

boolean

Alias
UMLS CUI [1,1]
C3888966
UMLS CUI [1,2]
C0151905
creatinine normal or creatinine clearance > 60 ml/min
Description

ID.14

Data type

boolean

Alias
UMLS CUI [1]
C0860945
prior concurrent therapy:
Description

ID.15

Data type

boolean

Alias
UMLS CUI [1]
C1514463
at least 4 weeks since prior chemotherapy
Description

ID.16

Data type

boolean

Alias
UMLS CUI [1]
C1514457
at least 4 weeks since prior biologic therapy
Description

ID.17

Data type

boolean

Alias
UMLS CUI [1]
C0278947
at least 4 weeks since prior radiotherapy
Description

ID.18

Data type

boolean

Alias
UMLS CUI [1]
C0279134
at least 30 days since prior investigational agents
Description

ID.19

Data type

boolean

Alias
UMLS CUI [1]
C1875319
no concurrent dehydroepiandrosterone or androstenedione supplements
Description

ID.20

Data type

boolean

Alias
UMLS CUI [1,1]
C0011185
UMLS CUI [1,2]
C0002860
no concurrent chemotherapy or radiotherapy
Description

ID.21

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1522449
UMLS CUI [1,3]
C0332155
no concurrent hormone therapy or immunotherapy (including trastuzumab [herceptin®])
Description

ID.22

Data type

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C0021083
UMLS CUI [1,3]
C0332155
Back to the top of the page

Similar models

Eligibility Breast Cancer NCT00516542

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
ID.1
Item
diagnosis of breast cancer
boolean
C0011900 (UMLS CUI [1,1])
C0006142 (UMLS CUI [1,2])
ID.2
Item
metastatic disease
boolean
C0027627 (UMLS CUI [1])
ID.3
Item
hormone receptor status
boolean
C0019929 (UMLS CUI [1])
ID.4
Item
estrogen receptor- and progesterone receptor-negative
boolean
C0279756 (UMLS CUI [1,1])
C0279766 (UMLS CUI [1,2])
ID.5
Item
androgen receptor-positive
boolean
C2986463 (UMLS CUI [1])
ID.6
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
ID.7
Item
ecog performance status 0-3
boolean
C1520224 (UMLS CUI [1])
ID.8
Item
postmenopausal (> 60 years of age)
boolean
C0232970 (UMLS CUI [1])
ID.9
Item
leukocyte count > 3,000/ul
boolean
C0023508 (UMLS CUI [1])
ID.10
Item
absolute neutrophil count > 1,500/ul
boolean
C0200633 (UMLS CUI [1])
ID.11
Item
platelet count > 100,000/ul
boolean
C0032181 (UMLS CUI [1])
ID.12
Item
total bilirubin normal
boolean
C0858307 (UMLS CUI [1])
ID.13
Item
ast and alt < 2.5 times upper limit of normal
boolean
C3888966 (UMLS CUI [1,1])
C0151905 (UMLS CUI [1,2])
ID.14
Item
creatinine normal or creatinine clearance > 60 ml/min
boolean
C0860945 (UMLS CUI [1])
ID.15
Item
prior concurrent therapy:
boolean
C1514463 (UMLS CUI [1])
ID.16
Item
at least 4 weeks since prior chemotherapy
boolean
C1514457 (UMLS CUI [1])
ID.17
Item
at least 4 weeks since prior biologic therapy
boolean
C0278947 (UMLS CUI [1])
ID.18
Item
at least 4 weeks since prior radiotherapy
boolean
C0279134 (UMLS CUI [1])
ID.19
Item
at least 30 days since prior investigational agents
boolean
C1875319 (UMLS CUI [1])
ID.20
Item
no concurrent dehydroepiandrosterone or androstenedione supplements
boolean
C0011185 (UMLS CUI [1,1])
C0002860 (UMLS CUI [1,2])
ID.21
Item
no concurrent chemotherapy or radiotherapy
boolean
C0392920 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0332155 (UMLS CUI [1,3])
ID.22
Item
no concurrent hormone therapy or immunotherapy (including trastuzumab [herceptin®])
boolean
C0279025 (UMLS CUI [1,1])
C0021083 (UMLS CUI [1,2])
C0332155 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial